About the Institute of Molecular and Cell Biology (IMCB)

Established in 1987 within the National University of Singapore, IMCB has a rich history of scientific innovation and excellence. Its founding Director, Prof Chris Y H Tan, along with an esteemed international Scientific Advisory Board chaired by Nobel Laureate Dr. Sydney Brenner, laid the foundation for the institute's global reputation. The advisory board included prominent figures such as Professors Louis Lim, Chua Nam Hai, and Alice Huang. As Pioneers of the Past, IMCB has played a pivotal role in shaping biomedical research in Singapore.

In 2002, IMCB expanded its research capabilities by integrating the Institute of Molecular Agrobiology (IMA), which brought additional strengths in structural biology and zebrafish research. This merger further solidified IMCB's position as a leader in life sciences research, exemplified by its receipt of the prestigious Nikkei 2000 Award.

IMCB is deeply committed to fostering collaboration with stakeholders across Singapore's scientific ecosystem. As Innovators of the Present, this collaborative approach ensures that IMCB remains at the forefront of scientific discovery while nurturing the next generation of scientists. Over the years, IMCB's research has evolved to focus on critical areas of human health, including Neuroscience and Neuro-Aging, Cancer Research, and Nucleic Acid and Cellular Therapy, with the aim of developing innovative therapies and treatments.

Looking ahead, as Trailblazers for the Future, IMCB is dedicated to advancing biomedical research and creating transformative health solutions for the next generation.